Russell Investments Group
IMVT icon

Russell Investments Group’s Immunovant IMVT Stock Holding History

Russell Investments Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
42,943
+34,798
+427% +$1.06M ﹤0.01% 2193
2026
Q1 		$202K Buy
8,145
+952
+13% +$24.6K ﹤0.01% 2849
2025
Q4 		$183K Sell
7,193
-190
-3% -$4.24K ﹤0.01% 2873
2025
Q3 		$119K Buy
7,383
+5,605
+315% +$90.7K ﹤0.01% 2973
2025
Q2 		$28.5K Buy
1,778
+132
+8% +$2K ﹤0.01% 3117
2025
Q1 		$28.1K Sell
1,646
-221,160
-99% -$4.63M ﹤0.01% 3038
2024
Q4 		$5.52M Sell
222,806
-28,686
-11% -$814K 0.01% 1117
2024
Q3 		$7.17M Buy
251,492
+76,297
+44% +$2.25M 0.01% 1007
2024
Q2 		$4.63M Sell
175,195
-1,151
-0.7% -$32.7K 0.01% 1187
2024
Q1 		$5.7M Sell
176,346
-555
-0.3% -$20.2K 0.01% 1106
2023
Q4 		$7.45M Buy
176,901
+136,418
+337% +$5.02M 0.01% 935
2023
Q3 		$1.55M Buy
+40,483
New +$915K ﹤0.01% 1692
2021
Q1 		– Sell
-44,956
Closed -$2.08M – 3154
2020
Q4 		$2.08M Buy
44,956
+39,956
+799% +$1.85M ﹤0.01% 1738
2020
Q3 		$175K Buy
+5,000
New +$150K ﹤0.01% 2816

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Russell Investments Group's IMVT Position: Q2 2026 in Review

Russell Investments Group increased its Immunovant (IMVT) stake by 427% in Q2 2026, buying an estimated $1.06M and bringing the position to 42,943 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Russell Investments Group first reported a position in IMVT in Q3 2020 and has held it in 14 quarters since. The position peaked at $7.45M in Q4 2023. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Russell Investments Group held 42,943 shares of Immunovant worth $1.65M as of Q2 2026.
  • Russell Investments Group bought 34,798 Immunovant shares in Q2 2026, an estimated $1.06M.
  • Immunovant made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2193 holding.
  • Russell Investments Group first reported a position in Immunovant in Q3 2020 and has held it in 14 quarters since.
  • Russell Investments Group's Immunovant position peaked at $7.45M in Q4 2023.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.